Prednisone reduces ketoconazole-induced skeletal defects in rat fetuses

[1]  V. C. S. Amaral,et al.  Ketoconazole- and fluconazole-induced embryotoxicity and skeletal anomalies in wistar rats: a comparative study , 2008 .

[2]  A. Czeizel,et al.  Population‐based case–control study of oral ketoconazole treatment for birth outcomes , 2005, Congenital anomalies.

[3]  L. Eichenfield,et al.  Long-term safety of tacrolimus ointment in children treated for atopic dermatitis , 2003, Expert opinion on drug safety.

[4]  J. Sobel,et al.  Antifungal drugs in pregnancy: a review , 2003, Expert opinion on drug safety.

[5]  J. Schlatter,et al.  Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase. , 2002, Environmental health perspectives.

[6]  J. Sobel.  Use of Antifungal Drugs in Pregnancy , 2000, Drug safety.

[7]  D. Sheehan,et al.  Current and Emerging Azole Antifungal Agents , 1999, Clinical Microbiology Reviews.

[8]  J. Cleary,et al.  Antifungal therapy during pregnancy. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  J. Laskey,et al.  Ketoconazole impairs early pregnancy and the decidual cell response via alterations in ovarian function. , 1997, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[10]  D. Acosta,et al.  Comparison of ketoconazole- and fluconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes. , 1995, Toxicology.

[11]  K. Tomecki.  Oral azole drugs as systemic antifungal therapy: Como JA, Dismukes WE. N Engl J Med 1994; 330:263–272 , 1995 .

[12]  S. Ge.  Oral azole drugs as systemic antifungal therapy. , 1994 .

[13]  Jackson A. Como,et al.  Oral azole drugs as systemic antifungal therapy. , 1994, The New England journal of medicine.

[14]  H. Bossche.  Inhibitors of P450-dependent steroid biosynthesis: From research to medical treatment , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  C. Jaspers,et al.  The influence of ketoconazole on human adrenal steroidogenesis: incubation studies with tissue slices , 1991, Clinical endocrinology.

[16]  P. Vanparys,et al.  Safety aspects of oral antifungal agents. , 1990, British journal of clinical practice. Supplement.

[17]  P. Vanparys,et al.  Toxicological Profile and Safety Evaluation of Antifungal Azole Derivatives , 1989, Mycoses.

[18]  N. Sonino.  The use of ketoconazole as an inhibitor of steroid production. , 1987, The New England journal of medicine.

[19]  A. Iranmanesh,et al.  Effect of Ketoconazole on the 11-Hydroxylation Step of Adrenal Steroidogenesis , 1987, Southern medical journal.

[20]  C. Fish.  Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk , 1986 .

[21]  H. Bossche.  Biochemical Targets for Antifungal Azole Derivatives: Hypothesis on the Mode of Action , 1985 .

[22]  H. Vanden Bossche.  Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. , 1985, Current topics in medical mycology.

[23]  D. Feldman,et al.  Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. , 1983, The Journal of clinical investigation.

[24]  G. Macdonald.  Factors involved in maintenance of pregnancy in the rat. The temporal need for estrogen, pituitary prolactin and the ovary. , 1978, Biology of reproduction.

[25]  C. Kimmel,et al.  Skeletal deviations in rats: malformations or variations? , 1973, Teratology.

[26]  W. M. Heller.  American Hospital Formulary Service , 1958 .